Evidence map›Paper›PMID 38530580›Full record

ArticleForensic science, medicine, and pathology2024

Assessment of pheniramine in alternative biological matrices by liquid chromatography tandem mass spectrometry.

Humera Shafi Makhdoom, Ali Imran Abid, Majida Mujahid, Saira Afzal, Kishwar Sultana, Nisar Hussain, Kashif Barkat

Abstract read
PubMed Publisher
In one paragraph

Article in Forensic science, medicine, and pathology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Interpol review of forensic drug chemistry, 2022-2025.Forensic science international. Synergy · 2026
    Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Humera Shafi MakhdoomFaculty of Pharmacy, University of Lahore, Lahore, Pakistan.
Ali Imran AbidUniversité de Strasbourg, INSERM, Régénérative nanomédecine UMR 1260, Centre de Recherche en Biomédecine de Strasbourg (CRBS), F-67000, Strasbourg, France. ali.imranabid50@gmail.com.
Majida MujahidFaculty of Pharmacy, University of Lahore, Lahore, Pakistan.
Saira AfzalFaculty of Pharmacy, University of Lahore, Lahore, Pakistan.
Kishwar SultanaDepartment of Pharmacy and Allied Health Sciences, Iqra University Islamabad Campus, Islamabad, Pakistan.
Nisar HussainFaculty of Pharmacy, University of Lahore, Lahore, Pakistan.
Kashif BarkatClinical and Forensic Toxicology Department, Chughtai Healthcare, Lahore, Pakistan.
University of Lahore · PKIqra University · PKPakistan Nuclear Regulatory Authority · PKRegenerative NanoMedicine · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pheniramine is an over-the-counter antihistamine drug. Its accessibility and low cost made it more popular among drug abusers in Pakistan. In this study, pheniramine was quantified in both conventional and alternative specimens of twenty chronic drug abusers, aged 16-50 years, who were positive for pheniramine in comprehensive toxicological screening for drugs by gas chromatography with mass spectral detection in positive electron impact mode. Pheniramine was extracted from biological specimens using solid phase extraction and liquid chromatography tandem mass spectrometry was employed for quantification. Chromatographic separation was carried out on a Poroshell120EC-18 (2.1 mm × 50 mm × 2.7 µm) column using water-acetonitrile in formic acid (0.1%) mobile phase in gradient elution mode with 500 μL/min flow rate. Positive electrospray ionization mode and multi-reaction monitoring with ion transitions m/z 241.3 → 195.8 and 167.1 for pheniramine and m/z m/z 247.6 → 173.1 for pheniramine-d6 were employed. The quantification method showed good linear ranges of 2-1000 ng/mL in blood, urine, and oral fluid; 2-1000 ng/mg in hair and 5-1000 ng/mg in nail with ≥ 0.985% coefficient of linearity. The retention time of pheniramine was 3.0 ± 0.1 min. The detection and lower quantification limits were 1 ng/mL and 2 ng/mL for blood, urine, oral fluid and hair whereas 2.5 ng/mg and 5 ng/mg for nail, respectively. Mean extraction recovery and ionization suppression ranged 86.3-95.1% and -4.6 to -14.4% in the studied matrices. Intra-day and inter-day precision were 4.1-9.3% and 2.8-11.2%, respectively. Pheniramine levels in specimens of drug abusers were 23-480 ng/mL in blood, 72-735 ng/mL in urine, 25-379 ng/mL in oral fluid, 10-170 ng/mg in hair and 8-86 ng/mg in nail specimens. Alternative specimens are of utmost significance in clinical and medico-legal cases. In this study, authors compared matrix-matched calibration curves to blood calibration curve and obtained results within ± 10%; thereby justifying the use of blood calibration curve for urine, oral fluid, hair, and nail specimens.

Indexed as

Histamine H1 AntagonistsPheniramineSubstance Abuse DetectionAdolescentAdultChromatography, LiquidFemaleForensic ToxicologyHairHumansLimit of DetectionMaleMiddle AgedNailsSalivaSolid Phase ExtractionHistamine H1 AntagonistsPheniramineAbuseAlternativeConventionalLC-MS/MSPheniramine

Identifiers

PMID38530580
OpenAlexW4393191631

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.